Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00985231 · ClinicalTrials.gov registry record · NA
Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 272
- Enrollment target
NCT00985231: Completed NA study, sponsored by Bausch & Lomb Incorporated.
NCT00985231 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 272 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00985231, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 272 participants
- Enrollment target
Study Summary
This study is being conducted to evaluate Bausch \& Lomb PureVision Multi-Focal contact lenses compared to the Bausch \& Lomb SofLens59 contact lens when worn by adapted soft contact lens wearers on a daily wear basis.
Primary Outcome
Eyes with distance lens VA of 20/40 or worse at study exit between test and control lenses.
Interventions
- DEVICE PureVision Multi-Focal contact lenses
- DEVICE SofLens59 contact lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 272 participants |
| Start Date | 2009-09 |
| Est. Completion | 2009-12 |
| Phase | NA |
What the finished NCT00985231 record still lists
NCT00985231 is an interventional study that assigns participants to a tested intervention. The registered 272 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which PureVision Multi-Focal contact lenses is the first listed.
NCT00985231 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00985231 about?
NCT00985231 is a clinical study titled "Performance Evaluation of Contact Lenses Among a Population of Adapted Contact Lens Wearers". This study is being conducted to evaluate Bausch \& Lomb PureVision Multi-Focal contact lenses compared to the Bausch \& Lomb SofLens59 contact lens when worn by adapted soft contact lens wearers on a daily wear basis.
What is the current status of trial NCT00985231?
This trial is currently completed. It is a NA study. The enrollment target is 272 participants. The study started on 2009-09. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00985231?
The interventions under investigation include: PureVision Multi-Focal contact lenses (DEVICE), SofLens59 contact lens (DEVICE).
Who is sponsoring clinical trial NCT00985231?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00985231's enrollment target sits among peer trials
272 387th of 2000 higher than 1,614 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02468024 · 272 participants · Phase 3
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- NCT05519449 · 272 participants · Phase 1
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- NCT06035939 · 272 participants · NA
SMYLS Multi-site Trial
- NCT06083051 · 272 participants · NA
Differences in Postoperative Symptoms With Four Ureteral Stents
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia